drugset / Trial / NCT01060774

Bupivacaine Versus Lidocaine on Inflammatory Regulation

NCT01060774 ↗

Phase 4 Completed 11 enrolled University of Maryland
RandomizedParallel-groupTriple-blindOther

Summary

This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicine at the end of root canal surgery. Small pieces of gum will be taken before and after surgery and 2 days later to analyze chemicals that may be related to pain sensation.

Timeline

Start
2008-07
Primary completion
2009-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % —
Subject Lidocaine Other / unclassified 2 % —

Indications

No indication recorded.